References
- The Alzheimer’s Association . 2015 Alzheimer’s disease facts and figures . Alzheimers Dement.11 , 332 – 384 ( 2014 ).
- Lublin AL , GandyS . Amyloid-β oligomers: possible roles as key neurotoxins in Alzheimer’s disease . Mount Sinai J. Med. New York77 ( 1 ), 43 – 49 ( 2010 ).
- Viola KL , SbarboroJ , SurekaRet al. Towards non-invasive diagnostic imaging of early-stage Alzheimer’s disease . Nat. Nanotechnol.10 ( 1 ), 91 – 98 ( 2015 ).
- Alvarez-Erviti L , SeowY , YinHFet al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes . Nat. Biotechnol.29 ( 4 ), 341 – 345 ( 2011 ).
- Park T , SinghB , LiHet al. Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer’s disease . Biomaterials38 ( 41 ), 61 – 71 ( 2015 ).
- Cai H , WangY , McCarthyDet al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons . Nat. Neurosci.4 ( 3 ), 233 – 234 ( 2001 ).
- Bach P , AbelT , HoffmannCet al. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus . Cancer Res.73 ( 2 ), 865 – 874 ( 2013 ).
- Allen C , ParaskevakouG , IankovIet al. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity . Mol. Ther.16 ( 9 ), 1556 – 1564 ( 2008 ).
- Hasselbalch B , LassenU , HansenSet al. Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a Phase II trial . Neuro. Oncol.12 ( 5 ), 508 – 516 ( 2010 ).
- Allen C , OpyrchalM , AdercaIet al. Oncolytic measles virus strains have significant antitumor activity against glioma stem cells . Gene Ther.20 ( 4 ), 444 – 449 ( 2013 ).
- Kaluzova M , BourasA , MachaidzeR , HadjipanayisCG . Targeted therapy of glioblastoma stem-like cells and tumor non stem cells using cetuximab-conjugated iron-oxide nanoparticles . Oncotarget6 ( 11 ), 8788 – 8806 ( 2015 ).
- Lammers T , KoczeraP , FokongSet al. Theranostic USPIO-loaded microbubbles for mediating and monitoring blood–brain barrier permeation . Adv. Funct. Mater.25 ( 1 ), 36 – 43 ( 2015 ).
- Huang H-Y , LiuH-L , HsuP-Het al. A multitheragnostic nanobubble system to induce blood–brain barrier disruption with magnetically guided focused ultrasound . Adv. Mater.27 , 655 – 661 ( 2015 ).